Table 2. Specific inhA promoter mutations found in each drug-resistance category.
Mutation | -15C/T | -16A/G | -8T/C | -8T/A | Total |
---|---|---|---|---|---|
DST Category | |||||
INH Mono-Resistance | 19 (54%) | 0 | 0 | 16 (46%) | 35 |
MDR-TB | 123 (75%) | 0 | 0 | 40 (25%) | 163 |
Pre-XDR-TB | 21 (78%) | 0 | 0 | 6 (22%) | 27 |
XDR-TB | 2 (29%) | 0 | 0 | 5 (71%) | 7 |
TOTAL | 165 (71%) | 0 | 0 | 67 (29%) | 232 |
INH: isoniazid; DST: drug susceptibility testing; MDR: multidrug-resistant; XDR: extensively drug-resistant